Prof. Daniel Skovronsky: „Neutralizing antibodies can be an important therapeutic option for patients fighting this virus.”
FDA authorizes monoclonal antibody for treatment of COVID-19. The Food and Drug Administration (FDA) have issued an emergency use authorization for the investigational monoclonal antibody therapy called bamlanivimab, which Eli Lilly designed. The…